Melanoma

The discovery of "sneaky tumors" structures could promote the development of treatments that combine immunotherapy with the timed inhibition of relevant signaling pathways in tumor cells.

An Israeli-US team led by Weizmann Institute of Science researchers used a new data-driven approach to identify cancerous mutations that may be treatable with an off-the-shelf medicine.

The test relies on a collection of special optical fibers that are transparent in infrared light. One end of the fibers is connected to a device that evaluates the 'colors' in the infrared.

The study concluded that one in 36 males in the UK will contract melanoma throughout their life, compared to one in 47 women.

Preclinical in-vitrio research done by MediWound as well as existing research have found that bromelain has anti-cancer properties.

To avoid the immune system, melanoma breaks down the amino acid tryptophan, stopping cells from properly functioning, but the cancer cells are able to do so despite lacking tryptophan themselves.

Their findings were published in the August 2020 issue of 'Advanced Therapeutics' as the cover article.

Melanomas are a form of aggressive skin cancer. The scientists say that they have made a first and important step in developing novel treatments and eventually a cure.

Older age, male gender and non-Hispanic white race/ethnicity were all associated with an increased incidence of head and neck melanoma.

When fat cells were removed from the melanoma in laboratory tests, the cancer cells "calmed down and stopped migrating."